A Phase II Study of T-DXd Plus SRT in HER2-positive Breast Cancer Brain Metastases

NCT06088056 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

17

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Brain Metastases
Radiotherapy

Interventions

DRUG: Combination use of SRT with T-DXd

Sponsor

Fudan University